Express News | Abivax SA : Btig Initiates Coverage With Buy Rating; Price Target $43

ReutersMay 20 07:41 ET

BTIG Initiates Coverage On Abivax With Buy Rating, Announces Price Target of $43

BTIG analyst Julian Harrison initiates coverage on Abivax (NASDAQ:ABVX) with a Buy rating and announces Price Target of $43.

BenzingaMay 20 07:36 ET

Abivax Announces Presentation of Four Abstracts for Obefazimod in Ulcerative Colitis and Preclinical Colon Cancer Model at Digestive Disease Week 2024

Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical colon cancer model at Digestive Disease Week 2024 PARIS, France, May 8, 2024, 8:30 a.m. CEST – Abivax SA

GlobeNewswireMay 8 02:30 ET

Abivax Annual Ordinary and Extraordinary General Meeting of May 30, 2024 - Availability of the Preparatory Documents

Abivax annual ordinary and extraordinary general meeting of May 30, 2024 Availability of the preparatory documents PARIS, France, May 7, 2024, 10:00PM CEST – Abivax SA ((Euronext Paris &, NASDAQ:ABVX) ("Abivax" or

GlobeNewswireMay 7 16:00 ET

Express News | Abivax Shares Are Trading Higher After Guggenheim and Piper Sandler Initiated Coverage on the Stock With Bullish Ratings

BenzingaApr 29 07:38 ET

Express News | Guggenheim Initiates Coverage On Abivax With Buy Rating, Announces Price Target of $50

BenzingaApr 29 06:22 ET